NCT00904436View on ClinicalTrials.gov

Evaluation of Breathing Pattern and Dyspnea in Subjects With Tetraplegia

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

January 31, 2001

Study Completion Date

January 31, 2001

Conditions
DyspneaTetraplegia
Interventions
DRUG

ipratropium (Atrovent)

Bronchodilator Treatment: Subjects will inhale 1 unit dose vial of aerosolized ipratropium (500 mcg of ipratropium (Atrovent) mixed in 2.5 ml of saline).

Trial Locations (1)

10468

VA Medical Center, Bronx, The Bronx

All Listed Sponsors
lead

US Department of Veterans Affairs

FED

NCT00904436 - Evaluation of Breathing Pattern and Dyspnea in Subjects With Tetraplegia | Biotech Hunter | Biotech Hunter